semaglutide and epilepsy seizures Seizure Recurrence after GLP-1 Receptor Agonist Initiation in Adults with – CURE Epilepsy Semaglutide-induced status epilepticus GLP-1 Drugs Linked to Lower

The VA may cover tirzepatide (Mounjaro) for diabetes

Mitochondrial therapeutic interventions in Alzheimers disease

This kind of non-obvious insight is what separates truly innovative medications from incremental improvements

If approved, a personalized plan and prescription options are provided

This variability points to an important truth: genetic and behavioral factors determine how your body responds to medication cessation, not just the medication itself

Pros: One-time treatment Long-term weight loss supported by decades of research Often improves diabetes, blood pressure, and sleep apnea No lifelong medication costs Cons: Requires surgery and recovery Lifestyle changes are necessary For many patients with severe obesity, bariatric surgery remains the most effective long-term treatment available